Effect of nedocromil sodium on bronchial hyperreactivity in children with nonatopic asthma

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 6, 1997, Pages 503-506

  Fiocchi, Alessandro ^a,b   Riva, Enrica ^a   Santini, Isabella ^a   Bernardo, Luca ^a   Sala, Marco ^a   Mirri, G Paolo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b San Paolo Biomed Institute of Milan   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; NEDOCROMIL SODIUM; SALBUTAMOL;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0031435320     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63056-6     Document Type: Article

References (27)

1. Boushey HA, Holtzman MJ, Sheller JR. Bronchial hyperreactivity. Am Rev Respir Dis 1980;121:389-94.
2. Townley RG, Ryo UY, Koloktin SM, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis and control patients. J Allergy Clin Immunol 1975;56:429-34.
3. Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981;36:575-9.
4. Hargreave FE, Ramsdale EH, Kirby JG, O'Byrne PM. Asthma and the role of inflammation. Eur J Respir Dis 1986;69:16-20.
5. Van Essen-Zandvliet EE, Hughes MD, Waaldens HJ, et al. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Eur Respir J 1994;7:63-8.
6. Boner AL, Piacentini GL, Bonizzato L, et al. Effect of inhaled beclomethasone dipropionate on bronchial hyperreactivity in asthmatic children during maximal allergen exposure. Pediatric Pulmonol 1991;10:2-8.
7. Wasserman SI, Furukawa CT, Henochowicz SI, et al. Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. J Allergy Clin Immunol 1995;95:541-7.
8. Crimi E, Brusasco V, Crimi P. Effect of nedocromil sodium on the late asthmatic reaction to bronchial antigen challenge. J Allergy Clin Immunol 1989;83:985-90.
9. Church MK, Hutson PA, Holgate ST. Nedocromil sodium blocks the early and late phases of allergen challenge in a guinea pig model of asthma. J Allergy Clin Immunol 1993;92:177-82.
10. Kopferschmitt-Kubler MC, Hutt N, Bigot H, et al. Protective effect of nedocromil sodium on the dual asthmatic response to bronchial antigen challenge. Respiration 1993;60:21-6.
11. Konig P, Hordvik NL, Kreutz C. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induced asthma in adults. J Allergy Clin Immunol 1987;79:64-8.
12. Bigby B, Boushey H. Effects of nedocromil sodium on the bronchomotor response to sulphur dioxide in asthmatic patients. J Allergy Clin Immunol 1993;92:195-7.
13. Church MK, Holgate ST. Adenosine-induced bronchoconstriction and its inhibition by nedocromil sodium. J Allergy Clin Immunol 1993;92:190-4.
14. Foresi A, Chetta A, Pelucchi A, et al. Effect of inhaled disodium cromoglycate and nedocromil sodium on propranolol-induced bronchoconstriction. Ann Allergy 1993;70:159-63.
15. Robuschi M, Vaghi A, Simone P, Bianco S. Prevention of fog-induced bronchospasm by nedocromil sodium. Clin Allergy 1987;17:69-74.
16. Spezia E, Del Col G, Richelli C, et al. Nedocromil sodium vs. sodium cromoglycate pressurized aerosol in the prevention of bronchoconstriction induced by ultrasonic nebulized distilled water in asthmatic children, Pediatr Pulmonol 1993;16:243-7.
17. Bell EH, Timmers MC, Hermans J, et al. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis 1990;141:21-8.
18. Scadding JG. Definition and clinical categorization. In: Weiss EB, Segal MS, Stein M, eds. Bronchial asthma. Boston: Little, Brown & Co, 1985:3-14.
19. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Basel: Karger, 1987.
20. Galdès-Sebaldt M, McLaughlin FJ, Levison H. Comparison of cold air, ultrasonic mist, and methacholine inhalation as tests of bronchial reactivity in normal and asthmatic children. J Pediatr 1985;107:526-30.
21. Fiocchi A, Zuccotti GV, Sala M, et al. Compliance with pharmacologic prophylaxis and therapy in bronchial asthma. Ann Allergy 1994;73:135-40.
22. Crimi E, Violante B, Pellegrino R. Brusasco V. Effect of multiple doses of nedocromil sodium given after allergen inhalation in asthma. J Allergy Clinlmmunol 1993;92:777-83.
23. Mekori YA, Baram D, Goldberg A, et al. Nedocromil sodium inhibits T-cell function in vitro and in vivo. J Allergy Clin Immunol 1993;91:817-24.
24. Barnes PJ, Holgate ST, Laitinen LA, Pauwels R. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Exp Allergy 1995;25:771-87.
25. Konig P, Eigen H, Ellis MH, et al. The effect of nedocromil sodium on childhood asthma during the viral season. Am J Respir Crit Care Med 1995;152:1879-86.
26. Global initiative on asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report, March, 1993, NIH 95-3659, 1995.
27. Frazier CA. Anti-inflammatory treatment of asthma in children. What strategy is appropriate? N C Med J 1995;56:616-8.